Northrop Grumman's stock plummeted 8.01% during intraday trading on Tuesday, as the market reacted negatively to the defense contractor's second-quarter 2026 financial results.

The sharp decline came despite the company reporting quarterly sales that beat analyst estimates. The primary driver of investor selling was a miss on adjusted earnings per share, which came in at $6.77 compared to the consensus estimate of $6.82, representing a year-over-year decline. More concerning to analysts was the 23% drop in operating income and a significant 38% decline in operating income within the defense systems business, indicating execution challenges in key segments.

Investor sentiment was further weighed down by broader concerns about the defense sector's outlook, including potential pressures on future U.S. defense budgets and ongoing worries about the company's substantial capital expenditure requirements for programs like the B-21 bomber, which impacts medium-term free cash flow projections. While Northrop Grumman raised its full-year guidance and reported a record backlog, the market reaction highlighted persistent skepticism toward defense stocks amid the current geopolitical and fiscal environment.